Last reviewed · How we verify

NCT01858987: CRUNSHII

Stapler vs. LigaSure in Elective Hepatic Resection

Completed NA Last updated 9 October 2017
What this trial tests

NA trial testing Stapler hepatectomy in Liver Resection in 138 participants. Completed in 14 August 2014.

Timeline
2 November 2011
Primary endpoint
17 July 2014
14 August 2014

Quick facts

Lead sponsorHeidelberg University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment138
Start date2 November 2011
Primary completion17 July 2014
Estimated completion14 August 2014
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Heidelberg University

Who can join

18 and older, any sex, with Liver Resection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The optimal technique of parenchymal transection in liver surgery has remained a matter of controversial debate among hepatobiliary surgeons. The optimal technique should enable secure sealing of the vascular and biliary structures that results in low intraoperative blood loss as well as low postoperative complication rates. Although numerous devices have been introduced and are used widely, high-level evidence, randomized controlled trials, that evaluate efficacy and safety of these devices are scarce. In the present randomized controlled trial two techniques of hepatic resection using vascular staplers and the LigaSure vessel sealing device are compared. While the primary endpoint is intraoperative blood loss a set of general and surgical variables will be analyzed to evaluate efficacy and safety of both methods.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Randomized clinical trial of stapler hepatectomy versus LigaSure™ transection in elective hepatic resection.
    Fritzmann J, Kirchberg J, Sturm D, Ulrich AB, et al · · 2018 · cited 17× · PMID 30069876 · DOI 10.1002/bjs.10902
  2. Infrahepatic Inferior Vena Cava Clamping does not Increase the Risk of Pulmonary Embolism Following Hepatic Resection.
    Birgin E, Mehrabi A, Sturm D, Reißfelder C, et al · · 2021 · cited 7× · PMID 34047820 · DOI 10.1007/s00268-021-06159-4

Verify or expand the search:

Other recruiting trials for Liver Resection

Currently open trials in the same condition.

Other Heidelberg University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01858987.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing